ASX:PME 15 February 2026 - 28 June 2026

Pro Medicus Ltd is trading Thursday after the medical-imaging software firm gained A$6.06 in the previous session. Normal ASX trade is set to open shortly before 10 a.m. in Sydney. Tech stocks bounced back following an 8% drop over the last two sessions. Healthcare names traded higher too. Pro Medicus posted no fresh price-sensitive news on Wednesday. Its last filing is still the June 5 index rebalance notice.

Pro Medicus Ltd traded through its S&P/ASX 50 exit with barely any net move in price. Shares finished Tuesday at A$172.93, up just 0.08% from the A$172.80 close Friday, when the reshuffle hit. PME is up 36% from May 25. Turnover jumped Friday to 1.19 million, more than 58% the sum of Monday and Tuesday, showing most index-driven trades landed at the close of the rebalance. Buyers and sellers can't be seen in public data. ALS Ltd is set to join the S&P/ASX 50 next week, with Pro Medicus dropped from the list, S&P Dow Jones Indices said. The move is effective before Monday’s open. The index review showed Pro Medicus as an ASX 50 removal only, not flagged for

Pro Medicus gained A$1.84 to A$174.64 Monday after it dropped out of Australia’s large-cap benchmark, with the share move defying the usual index effect. Trading in the cash market was shut at press time, with pre-open set for 7 a.m. and regular session due about 10 a.m. AEST. S&P Dow Jones Indices has dropped Pro Medicus from the S&P/ASX 50, effective before Monday's open, but Pro Medicus stays in the S&P/ASX 100. The company's removal from the top 50 means it will shift into the MidCap 50, which tracks ASX 100 stocks not in the top 50. So instead of falling out of all major index portfolios, Pro Medicus lands in the mid-cap benchmark.

Pro Medicus Ltd ended Friday at A$172.80, adding A$5.19. Buyers came back to the medical-imaging software stock ahead of a benchmark index move. The Australian market is now shut for the weekend. Heavy trading, not the share price move itself, stood out. Nearly 1.3 million shares were traded—about four times what the stock usually sees—on the last day before Pro Medicus exits the S&P/ASX 50. ALS Ltd takes the spot when the index update kicks in before Monday’s open.

Pro Medicus Ltd shares kept much of their strong bounce Tuesday, as the market looked at a new AI product push from its Visage Imaging arm but weighed it against Pro Medicus’s high valuation. The stock ended up 15 cents at A$165.79, trading between A$160.29 and A$167.78, with about 341,000 shares moving. Visage is set to pitch its latest radiology software at SIIM26 in Pittsburgh this week. The company plans to show Visage 7 | CloudPACS, a cloud-based system for storing and displaying medical scans, along with Visage 7 | Reporting, an AI-optimised reporting tool. Visage said first North American go-lives are expected in either the third or fourth quarter of 2026. Co-founder and global chief technology officer Malte Westerhoff

Pro Medicus is coming off a 25.2% gain for the week, but now faces a new headwind when the ASX opens Tuesday. S&P Dow Jones Indices said it will kick the medical-imaging software group out of the S&P/ASX 50 after June 22. ALS will move into the index. Index changes can hit hard when markets are shut. With the Australian cash market closed Monday for the King’s Birthday, Friday’s close is still the last price until trading is back on. A rebalance just means an index provider switches up which stocks are in the benchmark.

Pro Medicus Ltd saw a strong rebound this week but now faces an index shakeup after S&P Dow Jones Indices decided to cut the medical-imaging software company from the S&P/ASX 50 later this month. The ASX is closed Monday for the King’s Birthday holiday, so traders will have to wait until the next session to react to the late-Friday announcement. That’s now front of mind since shares took off. Pro Medicus ended Friday at A$165.64, a gain of 4.03% on the day and about 25% higher than last week’s finish at A$132.26, according to Tiger Brokers market data.